Use of Methazolamide to Lower Intraocular Pressure
Status:
Not yet recruiting
Trial end date:
2023-08-07
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the effect of methazolamide, 25 mg or 50 mg tablets
once a day for a week than twice a day for a week, on lowering intraocular pressure and the
safety of methazolamide.